Mélanie Claps

1.1k total citations
57 papers, 692 citations indexed

About

Mélanie Claps is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mélanie Claps has authored 57 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Mélanie Claps's work include Renal cell carcinoma treatment (24 papers), Cancer Genomics and Diagnostics (16 papers) and Prostate Cancer Treatment and Research (14 papers). Mélanie Claps is often cited by papers focused on Renal cell carcinoma treatment (24 papers), Cancer Genomics and Diagnostics (16 papers) and Prostate Cancer Treatment and Research (14 papers). Mélanie Claps collaborates with scholars based in Italy, United States and United Kingdom. Mélanie Claps's co-authors include Giuseppe Procopio, Elena Verzoni, Pierangela Sepe, Filippo de Braud, Valentina Guadalupi, Alfredo Berruti, Marco Stellato, Alessia Mennitto, Emma Zattarin and Alessandra Raimondi and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Mélanie Claps

50 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélanie Claps Italy 15 384 291 261 227 220 57 692
Michael Kolinsky Canada 13 572 1.5× 197 0.7× 84 0.3× 361 1.6× 182 0.8× 54 824
W. M. Linehan United States 7 359 0.9× 229 0.8× 150 0.6× 125 0.6× 243 1.1× 12 690
Chia‐Chi Lin Taiwan 11 332 0.9× 125 0.4× 118 0.5× 326 1.4× 187 0.8× 25 637
Òscar Reig Spain 13 303 0.8× 153 0.5× 103 0.4× 218 1.0× 190 0.9× 56 562
Masatoshi Moriyama Japan 13 328 0.9× 169 0.6× 191 0.7× 152 0.7× 233 1.1× 47 590
Guo-Hai Shi China 16 371 1.0× 266 0.9× 130 0.5× 161 0.7× 379 1.7× 36 772
Christopher Tretter United States 8 668 1.7× 381 1.3× 361 1.4× 429 1.9× 471 2.1× 12 1.1k
Linda Cerbone Italy 13 233 0.6× 100 0.3× 167 0.6× 149 0.7× 183 0.8× 34 480
Amin H. Nassar United States 17 396 1.0× 216 0.7× 250 1.0× 454 2.0× 318 1.4× 74 886
Irene De Santo Italy 9 342 0.9× 213 0.7× 35 0.1× 394 1.7× 169 0.8× 13 692

Countries citing papers authored by Mélanie Claps

Since Specialization
Citations

This map shows the geographic impact of Mélanie Claps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Claps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Claps more than expected).

Fields of papers citing papers by Mélanie Claps

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Claps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Claps. The network helps show where Mélanie Claps may publish in the future.

Co-authorship network of co-authors of Mélanie Claps

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Claps. A scholar is included among the top collaborators of Mélanie Claps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Claps. Mélanie Claps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stellato, Marco, Ernesto Zecca, Mélanie Claps, et al.. (2025). Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis. Tumori Journal. 111(5). 442–446.
2.
Stellato, Marco, et al.. (2025). Pathological Complete Response in Metastatic Renal Cell Carcinoma Patients Treated With Cabozantinib Plus Nivolumab. Case Series and Literature Review. Clinical Genitourinary Cancer. 23(3). 102328–102328. 1 indexed citations
3.
4.
5.
Galsky, Matt D., Guru Sonpavde, Thomas Powles, et al.. (2024). Characterization of complete responders to nivolumab + gemcitabine-cisplatin vs gemcitabine-cisplatin alone and patients with lymph node–only metastatic urothelial carcinoma from the CheckMate 901 trial.. Journal of Clinical Oncology. 42(16_suppl). 4509–4509. 11 indexed citations
6.
7.
8.
Giannatempo, Patrizia, Valentina Guadalupi, Laura Marandino, et al.. (2023). Activity of cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy: Interim results from the phase 2 ARCADIA trial.. Journal of Clinical Oncology. 41(16_suppl). 4578–4578. 4 indexed citations
9.
Trama, Annalisa, Alice Bernasconi, Laura Botta, et al.. (2022). COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020. International Journal of Cancer. 151(9). 1502–1511. 5 indexed citations
10.
Nazzani, Sebastiano, Silvia Stagni, Davide Biasoni, et al.. (2022). Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumors. European Journal of Surgical Oncology. 49(1). 257–262.
11.
Mennitto, Alessia, Elena Verzoni, Francesco Cognetti, et al.. (2021). Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Expert Review of Clinical Pharmacology. 14(2). 261–268. 7 indexed citations
12.
Gandellini, Paolo, Chiara Maura Ciniselli, T. Rancati, et al.. (2021). Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables. Cancers. 13(10). 2433–2433. 9 indexed citations
13.
Raimondi, Alessandra, Pierangela Sepe, Mélanie Claps, et al.. (2020). Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori. Tumori Journal. 106(5). 406–412. 6 indexed citations
14.
Claps, Mélanie, Alessia Mennitto, Valentina Guadalupi, et al.. (2020). Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes. Cancer Treatment Reviews. 88. 102057–102057. 42 indexed citations
15.
Claps, Mélanie, Marco Stellato, Emma Zattarin, et al.. (2020). Current Understanding of Urachal Adenocarcinoma and Management Strategy. Current Oncology Reports. 22(1). 9–9. 27 indexed citations
16.
Raimondi, Alessandra, Pierangela Sepe, Emma Zattarin, et al.. (2020). Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer. Frontiers in Oncology. 10. 1644–1644. 45 indexed citations
17.
Pagani, Filippo, Maurizio Colecchia, Pierangela Sepe, et al.. (2019). Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives. Cancer Treatment Reviews. 79. 101891–101891. 21 indexed citations
18.
Claps, Mélanie, Fausto Petrelli, Orazio Caffo, et al.. (2018). Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis. Clinical Genitourinary Cancer. 16(3). 165–175.e2. 34 indexed citations
19.
Vassalli, Lucia, Rebecca Pedersini, E. Conti, et al.. (2017). Efficacy and patient acceptability of the DigniCaP ScalpCooler to prevent hair loss in breast cancer patients receiving adjuvant chemotherapy. Annals of Oncology. 28. vi107–vi107. 1 indexed citations
20.
Ferrari, Laura, Mélanie Claps, Salvatore Grisanti, & Alfredo Berruti. (2015). Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update. European Urology Focus. 1(3). 298–300. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Kolinsky Breakdown of academic impact, for papers by W. M. Linehan Breakdown of academic impact, for papers by Chia‐Chi Lin Breakdown of academic impact, for papers by Òscar Reig Breakdown of academic impact, for papers by Masatoshi Moriyama Breakdown of academic impact, for papers by Guo-Hai Shi Breakdown of academic impact, for papers by Christopher Tretter Breakdown of academic impact, for papers by Linda Cerbone Breakdown of academic impact, for papers by Amin H. Nassar Breakdown of academic impact, for papers by Irene De Santo
Rankless by CCL
2026